Keith Michael Gottesdiener - 05 Jun 2024 Form 4 Insider Report for Prime Medicine, Inc. (PRME)

Role
President and Chief Executive Officer, Director
Signature
/s/ Karen Brown, attorney-in-fact
Issuer symbol
PRME
Transactions as of
05 Jun 2024
Net transactions value
$0
Form type
4
Filing time
07 Jun 2024, 16:18:08 UTC
Previous filing
27 Feb 2024
Next filing
10 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRME Common Stock Gift $0 -250,000 -9.8% $0.000000 2,310,837 05 Jun 2024 Direct F1
transaction PRME Common Stock Gift $0 +250,000 +920% $0.000000 277,166 05 Jun 2024 By Spouse F1
holding PRME Common Stock 455,334 05 Jun 2024 By Trust F2
holding PRME Common Stock 1,317,741 05 Jun 2024 By Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 5, 2024, for bona fide estate planning purposes, the Reporting Person transferred 250,000 shares of Issuer common stock to his spouse for no consideration.
F2 Shares held by a trust for which certain of the Reporting Person's family member is a trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F3 Shares held by a trust for which the Reporting Person's spouse and certain of the Reporting Person's family member are co-trustees. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Remarks:

President and Chief Executive Officer